tiprankstipranks
MEDICLIN AG (DE:MED)
XETRA:MED
Germany Market
MED
MEDICLIN
RESEARCH TOOLSreports
Want to see DE:MED full AI Analyst Report?

MEDICLIN (MED) Ratios

1 Followers

MEDICLIN Ratios

DE:MED's free cash flow for Q1 2026 was €0.84. For the 2026 fiscal year, DE:MED's free cash flow was decreased by € and operating cash flow was €0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.74 1.62 1.79 1.75 1.53
Quick Ratio
 1.70 1.58 1.75 1.71 1.48
Cash Ratio
 0.47 0.44 0.65 0.67 0.52
Solvency Ratio
 0.05 0.14 0.11 0.11 0.11
Operating Cash Flow Ratio
 0.56 0.61 0.49 0.46 0.20
Short-Term Operating Cash Flow Coverage
 3.30 3.50 43.23 2.89 1.29
Net Current Asset Value
€ -292.19M€ -366.92M€ -385.58M€ -384.65M€ -444.78M
Leverage Ratios
Debt-to-Assets Ratio
 0.44 0.44 0.51 0.54 0.55
Debt-to-Equity Ratio
 1.46 1.57 2.09 2.45 2.40
Debt-to-Capital Ratio
 0.59 0.61 0.68 0.71 0.71
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.23 0.25 0.24
Financial Leverage Ratio
 3.31 3.53 4.07 4.49 4.38
Debt Service Coverage Ratio
 0.66 1.81 3.84 1.95 2.45
Interest Coverage Ratio
 2.41 1.85 2.23 0.53 1.84
Debt to Market Cap
 0.24 0.24 0.58 0.73 0.55
Interest Debt Per Share
 7.73 8.67 10.28 10.61 10.81
Net Debt to EBITDA
 6.85 3.23 3.35 3.60 4.52
Profitability Margins
Gross Profit Margin
15.14%14.51%83.20%81.44%81.16%
EBIT Margin
5.40%4.90%7.49%2.09%2.89%
EBITDA Margin
5.41%12.58%14.21%13.87%13.03%
Operating Profit Margin
6.13%4.90%7.14%1.74%2.77%
Pretax Profit Margin
5.08%4.49%4.29%-1.19%1.39%
Net Profit Margin
3.71%3.25%3.32%-1.48%1.34%
Continuous Operations Profit Margin
3.76%3.30%3.33%-1.47%1.38%
Net Income Per EBT
73.10%72.41%77.33%124.02%96.56%
EBT Per EBIT
82.78%91.57%60.05%-68.30%50.09%
Return on Assets (ROA)
3.49%2.90%2.74%-1.22%1.03%
Return on Equity (ROE)
11.90%10.24%11.16%-5.50%4.51%
Return on Capital Employed (ROCE)
7.21%5.36%7.23%1.79%2.62%
Return on Invested Capital (ROIC)
5.12%3.80%5.40%1.55%2.44%
Return on Tangible Assets
3.56%2.95%2.82%-1.26%1.10%
Earnings Yield
16.08%14.50%21.61%-8.40%5.52%
Efficiency Ratios
Receivables Turnover
 7.52 4.31 4.17 4.76 5.04
Payables Turnover
 117.36 46.13 9.77 10.73 9.16
Inventory Turnover
 113.00 122.98 16.41 18.57 14.97
Fixed Asset Turnover
 1.58 1.56 1.40 1.42 1.30
Asset Turnover
 0.94 0.89 0.83 0.83 0.77
Working Capital Turnover Ratio
 7.03 6.77 5.76 6.64 9.81
Cash Conversion Cycle
 48.68 79.71 72.41 62.33 56.92
Days of Sales Outstanding
 48.56 84.66 87.52 76.68 72.39
Days of Inventory Outstanding
 3.23 2.97 22.24 19.65 24.38
Days of Payables Outstanding
 3.11 7.91 37.36 34.01 39.84
Operating Cycle
 51.79 87.62 109.76 96.34 96.76
Cash Flow Ratios
Operating Cash Flow Per Share
 1.86 2.10 1.70 1.64 0.73
Free Cash Flow Per Share
 0.97 1.08 0.76 0.85 0.18
CapEx Per Share
 0.90 1.02 0.94 0.79 0.55
Free Cash Flow to Operating Cash Flow
 0.52 0.52 0.45 0.52 0.25
Dividend Paid and CapEx Coverage Ratio
 1.99 1.98 1.80 2.08 1.33
Capital Expenditure Coverage Ratio
 2.07 2.06 1.80 2.08 1.33
Operating Cash Flow Coverage Ratio
 0.25 0.26 0.17 0.16 0.07
Operating Cash Flow to Sales Ratio
 0.12 0.13 0.11 0.11 0.05
Free Cash Flow Yield
28.47%29.27%31.21%31.52%5.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.50 6.90 4.63 -11.90 18.11
Price-to-Sales (P/S) Ratio
 0.23 0.22 0.15 0.18 0.24
Price-to-Book (P/B) Ratio
 0.75 0.71 0.52 0.65 0.82
Price-to-Free Cash Flow (P/FCF) Ratio
 3.67 3.42 3.20 3.17 19.84
Price-to-Operating Cash Flow Ratio
 2.02 1.76 1.43 1.64 4.94
Price-to-Earnings Growth (PEG) Ratio
 0.58 1.79 -0.01 0.06 0.03
Price-to-Fair Value
 0.75 0.71 0.52 0.65 0.82
Enterprise Value Multiple
 11.04 5.01 4.43 4.87 6.38
Enterprise Value
 462.27M 494.40M 471.51M 492.79M 585.63M
EV to EBITDA
 10.87 5.01 4.43 4.87 6.38
EV to Sales
 0.59 0.63 0.63 0.67 0.83
EV to Free Cash Flow
 9.50 9.61 13.14 12.19 67.93
EV to Operating Cash Flow
 4.92 4.95 5.85 6.32 16.91
Tangible Book Value Per Share
 4.69 4.90 4.17 3.65 3.24
Shareholders’ Equity Per Share
 5.01 5.24 4.68 4.12 4.40
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.22 -0.23 <0.01
Revenue Per Share
 15.60 16.52 15.76 15.37 14.84
Net Income Per Share
 0.58 0.54 0.52 -0.23 0.20
Tax Burden
 0.73 0.72 0.77 1.24 0.97
Interest Burden
 0.94 0.92 0.57 -0.57 0.48
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.08 0.10 0.03 0.02 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 3.18 3.92 3.23 -7.24 3.56
Currency in EUR